Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | neuropeptide S receptor 1 | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific demethylase 4A | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0189 | 0.0189 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.019 | 0.019 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0045 | 0.0045 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0115 | 0.0604 | 0.0604 |
Entamoeba histolytica | hypothetical protein | 0.0888 | 0.6436 | 0.4682 |
Mycobacterium tuberculosis | Probable deoxycytidine triphosphate deaminase Dcd (dCTP deaminase) | 0.0473 | 0.3298 | 0.5 |
Mycobacterium ulcerans | deoxyuridine 5'-triphosphate nucleotidohydrolase | 0.0473 | 0.3298 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0045 | 0.0045 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0568 | 0.4018 | 0.4018 |
Brugia malayi | jmjC domain containing protein | 0.0115 | 0.0604 | 0.0604 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0043 | 0.0056 | 0.0056 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 0.602 | 0.602 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0189 | 0.0189 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0833 | 0.602 | 0.602 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1278 | 0.1278 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0049 | 0.0104 | 0.0104 |
Echinococcus granulosus | neuropeptide s receptor | 0.0568 | 0.4018 | 0.4018 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0568 | 0.4018 | 0.4018 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.0056 | 0.0056 |
Echinococcus granulosus | geminin | 0.0205 | 0.1278 | 0.1278 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0045 | 0.0045 |
Schistosoma mansoni | jumonji domain containing protein | 0.0092 | 0.0425 | 0.0425 |
Entamoeba histolytica | hypothetical protein | 0.0888 | 0.6436 | 0.4682 |
Brugia malayi | jmjC domain containing protein | 0.0043 | 0.0056 | 0.0056 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0115 | 0.0604 | 0.0604 |
Echinococcus granulosus | jumonji domain containing protein | 0.0049 | 0.0104 | 0.0104 |
Mycobacterium ulcerans | deoxycytidine triphosphate deaminase | 0.0473 | 0.3298 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0189 | 0.0189 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0073 | 0.0283 | 0.0283 |
Mycobacterium leprae | PROBABLE DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE DCD (DCTP DEAMINASE) | 0.0473 | 0.3298 | 0.5 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0043 | 0.0056 | 0.0056 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0189 | 0.0189 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0568 | 0.4018 | 0.4018 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0043 | 0.0056 | 0.0056 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 0.602 | 0.602 |
Echinococcus multilocularis | geminin | 0.0205 | 0.1278 | 0.1278 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.0056 | 0.0056 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1278 | 0.1278 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.4581 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.2387 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 4.4668 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 4.6535 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 7.0795 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.081 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.